The present invention relates to a novel human protein called Dendritic Enriched
Secreted Lymphocyte Activation Molecule, and isolated polynucleotides encoding
this protein. Also provided are vectors, host cells, antibodies, and recombinant
methods for producing this human protein. The invention further relates to diagnostic
and therapeutic methods useful for diagnosing and treating disorders related to
this novel human protein.